Holen Sie sich die Stockscreener-App
393.42
22.63%
-115.04
Vorhandelsmarkt:
393.42
Schlusskurs vom Vortag:
$508.46
Offen:
$375.15
24-Stunden-Volumen:
1.63M
Relative Volume:
4.26
Marktkapitalisierung:
$11.24B
Einnahmen:
$2.53B
Nettoeinkommen (Verlust:
$451.12M
KGV:
25.73
EPS:
15.2927
Netto-Cashflow:
$681.87M
1W Leistung:
-23.70%
1M Leistung:
-13.90%
6M Leistung:
-34.06%
1J Leistung:
+35.41%
1-Tages-Spanne:
$373.00
$407.61
1-Wochen-Bereich:
$373.00
$530.08
52-Wochen-Spanne:
$284.10
$628.92
Medpace Holdings Inc Stock (MEDP) Company Profile
Firmenname
Medpace Holdings Inc
Sektor
Branche
Telefon
(513) 579-9911
Adresse
5375 MEDPACE WAY, CINCINNATI, OH
Compare MEDP vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MEDP
Medpace Holdings Inc
|
393.42 | 14.70B | 2.53B | 451.12M | 681.87M | 15.29 |
TMO
Thermo Fisher Scientific Inc
|
466.70 | 194.94B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
178.57 | 137.69B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
560.93 | 45.19B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
114.42 | 34.50B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
311.20 | 32.91B | 3.17B | 642.63M | 516.49M | 10.77 |
Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-06 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2026-03-03 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-02-18 | Hochstufung | TD Cowen | Sell → Hold |
| 2026-02-13 | Hochstufung | Jefferies | Hold → Buy |
| 2026-02-10 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-10-02 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2025-09-03 | Herabstufung | Rothschild & Co Redburn | Buy → Neutral |
| 2025-07-29 | Herabstufung | UBS | Neutral → Sell |
| 2025-07-23 | Herabstufung | TD Cowen | Hold → Sell |
| 2025-06-24 | Eingeleitet | Barclays | Equal Weight |
| 2025-04-22 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-04-14 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-03-24 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-10-23 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-09-27 | Herabstufung | UBS | Buy → Neutral |
| 2024-09-25 | Herabstufung | Jefferies | Buy → Hold |
| 2024-08-01 | Eingeleitet | Truist | Hold |
| 2024-05-29 | Eingeleitet | TD Cowen | Buy |
| 2024-05-28 | Eingeleitet | Mizuho | Buy |
| 2024-04-23 | Hochstufung | Jefferies | Hold → Buy |
| 2024-03-18 | Eingeleitet | Deutsche Bank | Hold |
| 2024-02-15 | Hochstufung | UBS | Neutral → Buy |
| 2023-10-24 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2023-05-08 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-10-27 | Hochstufung | UBS | Sell → Neutral |
| 2022-09-07 | Eingeleitet | UBS | Sell |
| 2022-05-24 | Eingeleitet | Guggenheim | Neutral |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-10-02 | Hochstufung | Truist | Hold → Buy |
| 2020-06-08 | Hochstufung | Robert W. Baird | Underperform → Neutral |
| 2020-05-13 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-04-30 | Hochstufung | SunTrust | Sell → Hold |
| 2020-04-20 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2020-03-17 | Herabstufung | SunTrust | Hold → Sell |
| 2020-01-27 | Herabstufung | SunTrust | Buy → Hold |
| 2018-10-31 | Hochstufung | SunTrust | Hold → Buy |
| 2018-09-17 | Eingeleitet | SunTrust | Hold |
| 2018-07-31 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2017-11-01 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2017-09-29 | Eingeleitet | Raymond James | Mkt Perform |
| 2017-07-10 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
Alle ansehen
Medpace Holdings Inc Aktie (MEDP) Neueste Nachrichten
Medpace Holdings Balances Strong Q1 With Booking Risks - TipRanks
Medpace (MEDP) Reports Q1 2026 Earnings with Rising Cancellations - GuruFocus
Medpace Holdings Inc (MEDP) Shares Fall 22.7% -- What GF Score o - GuruFocus
[10-Q] Medpace Holdings, Inc. Quarterly Earnings Report - Stock Titan
Medpace Holdings stock plummets after earnings release - The Business Journals
Medpace Q1 Earnings Call Highlights - Yahoo Finance
Medpace (MEDP) Sees Significant Drop of 24.5% - GuruFocus
Medpace Flags Rising Cancellations, Near-Term Growth Uncertain - Benzinga
Medpace (MEDP) Faces Significant Drop in Stock Price - GuruFocus
CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Highlights Class Action Against Medpace Holdings and Upcoming Lead Plaintiff Deadline of June 8, 2026 - 巴士的報
INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
Medpace Q1 2026 slides: strong growth masks deceleration concerns By Investing.com - Investing.com South Africa
Deadline Alert: Medpace Holdings, Inc. (MEDP) Shareholders - GlobeNewswire
Medpace (MEDP) Q1 2026 Earnings Transcript - The Motley Fool
Transcript : Medpace Holdings, Inc., Q1 2026 Earnings Call, Apr 23, 2026 - marketscreener.com
Earnings call transcript: Medpace Holdings Q1 2026 sees earnings beat but stock tumbles - Investing.com
Transcript: Medpace Hldgs Q1 2026 Earnings Conference CallMedpace Holdings (NASDAQ:MEDP) - Benzinga
Deutsche Bank Cuts Price Target on Medpace Holdings to $425 From $480, Keeps Hold Rating - marketscreener.com
ASGN posts downbeat Q1 results, joins Medpace, ServiceNow and other big stocks moving lower in Thursday's pre-market session - MSN
Medpace Holdings, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:MEDP) 2026-04-23 - Seeking Alpha
Portnoy Law Firm Announces Class Action on Behalf of Medpace Holdings, Inc. Investors - GlobeNewswire
Medpace Holdings, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
ASGN Posts Downbeat Q1 Results, Joins Medpace, ServiceNow And Other Big Stocks Moving Lower In Thursday's - Benzinga
Medpace Holdings revenue up 26.5% to USD 706.6M in Q1 2026 - Medical Buyer
S&P 500 Futures Drop In Premarket Trading; Houlihan Lokey, Medpace Holdings Lag - 富途牛牛
Medpace: Q1 Earnings Snapshot - theheraldreview.com
Medpace falls despite Q1 beats; 2026 guidance ranges include consensus - MSN
Medpace (MEDP) Reports Strong Q1 2026 Earnings, Beating Expectat - GuruFocus
Medpace (MEDP) Q1 Earnings and Revenues Beat Estimates - Yahoo Finance
Medpace Holdings, Inc. Reports First Quarter 2026 Results - Investing News Network
Medpace Holdings (MEDP) Reports Strong Q1 Earnings Amid Leadersh - GuruFocus
Medpace Holdings Inc forecasts 2026 revenue $2.755 billion-$2.855 billion, up 8.9%-12.8% - marketscreener.com
Medpace Holdings Inc Forecasts 2026 Revenue $2.755 Billion-$2.855 Billion, Up 8.9%-12.8% - TradingView
Is Medpace (MEDP) Overvalued After Q1 2026 Earnings Beat? GAAP E - GuruFocus
Medpace slides 20.8% as Q1 book-to-bill drops below 1 and president retirement is disclosed - Quiver Quantitative
Medpace Announces Strong Q1 Results Amid Leadership Transition - TipRanks
On April 21, 2026, Medpace Holdings Inc. announced that its President, Jesse Geiger, has officially notified the Board of Directors of his intention to resign from his position as President. - Bitget
Medpace’s (NASDAQ:MEDP) Q1 CY2026 Sales Beat Estimates But Stock Drops 19.8% - Yahoo Finance
MEDP SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Medpace Holdings, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Medpace Q1 Earnings, Revenue Rise - marketscreener.com
Medpace Holdings Inc. (MEDP) Stock Falls on Q1 2026 Earnings - Quiver Quantitative
(MEDP) Medpace Expects 2026 EPS Range $16.68-$17.50, vs. FactSet Est of $17.16 - marketscreener.com
(MEDP) Medpace Expects 2026 Revenue Range $2.755B-$2.855B, vs. FactSet Est of $2.81B - marketscreener.com
Earnings Flash (MEDP) Medpace Posts Q1 EPS $4.28, vs. FactSet Est of $3.92 - marketscreener.com
Medpace : MEDP 1Q26 Earnings Presentation - marketscreener.com
Earnings Flash (MEDP) Medpace Holdings, Inc. Reports Q1 Revenue $706.6M, vs. FactSet Est of $697.6M - marketscreener.com
Medpace Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Strong Q1 2026 growth for Medpace (NASDAQ: MEDP) with raised outlook - Stock Titan
Medpace Holdings, Inc. Provides Earnings Guidance for the Year 2026 - marketscreener.com
Medpace Holdings Faces Investor Lawsuit Over Alleged Misleading Book-to-Bill Guidance - TipRanks
Medpace earnings in focus: Can bookings rebound after Q4 setback? By Investing.com - Investing.com South Africa
Finanzdaten der Medpace Holdings Inc-Aktie (MEDP)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):